| Complication | Mechanism | Frequency |
|---|---|---|
| Light-chain nephropathy | Direct tubular toxicity of free light chains; cast formation in distal tubules | Very common (50%) |
| Hyperviscosity syndrome | High concentration of monoclonal immunoglobulin (especially IgM, IgA) | 5–10% (more common in Waldenström) |
| Tumor lysis syndrome | Rapid cell death releases intracellular contents (K⁺, phosphate, uric acid) | Uncommon spontaneously; common post-chemo |
| Infections | Suppressed normal immunoglobulin production; impaired cell-mediated immunity | Very common |
| Hypercalcemia | Osteoclastic bone resorption; impaired renal excretion | 20–30% |
| Leukemoid reaction | Secondary to infection or inflammatory response, NOT direct myeloma effect | Uncommon and secondary |
Acute leukemoid reaction with WBC >50,000/μL is NOT a direct complication of myeloma cell proliferation. While myeloma patients can develop leukemoid reactions in response to infection or stress, this is a secondary phenomenon, not a primary manifestation of the disease. The other three options (light-chain nephropathy, hyperviscosity syndrome, and tumor lysis syndrome) are well-established, direct complications of myeloma.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →